BACH1 and B-cell non-Hodgkin lymphoma: When the human B cell line derived from B cell lymphoma was treated with the TBK1 inhibitors, BACH1 protein amount was increased (Figure 5C), suggesting the universality of BACH1 protein regulation by TBK1.